HPR57 Do Favourable Access Conditions and Policies for Biosimilars Result in Increased Consumption in the EU4 and the UK?

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1189
https://www.valueinhealthjournal.com/article/S1098-3015(22)03394-0/fulltext
Title : HPR57 Do Favourable Access Conditions and Policies for Biosimilars Result in Increased Consumption in the EU4 and the UK?
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03394-0&doi=10.1016/j.jval.2022.09.1189
First page :
Section Title :
Open access? : No
Section Order : 10739
Categories :
Tags :
Regions :
ViH Article Tags :